250
Participants
Start Date
February 28, 2001
Primary Completion Date
February 28, 2006
fluorouracil
High dose 5-FU
gemcitabine hydrochloride
Normal dose to treat pancreatic cancer
triacetyluridine
6 grams (12 tablets)
New York Weill Cornell Cancer Center at Cornell University, New York
Queens Medical Associates, PC, Fresh Meadows
Fox Chase - Temple Cancer Center, Philadelphia
Wellstat Therapeutics, Gaithersburg
Cancer Centers of the Carolinas - Eastside, Greenville
St. Joseph's Hospital, Savannah
Florida Oncology Associates - South Side, Jacksonville
Memorial Cancer Institute at Memorial Regional Hospital, Hollywood
Northwest Oncology and Hematology Associates, Coral Springs
University of Miami Sylvester Comprehensive Cancer Center, Miami
Florida Cancer Specialists - World Plaza, Fort Myers
Florida Cancer Institute - New Port Richey, New Port Richey
Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham
Summit Oncology Associates, Akron
Cancer Care Center, New Albany
CCOP - Metro-Minnesota, Saint Louis Park
David C. Pratt Cancer Center at St. John's Mercy, St Louis
Capitol Comprehensive Cancer Care Clinic, Jefferson City
Corpus Christi Cancer Center, Corpus Christi
Providence Saint Joseph Medical Center - Burbank, Burbank
Scripps Cancer Center at Scripps Clinic, La Jolla
Brookwood Medical Center, Birmingham
City of Hope Comprehensive Cancer Center, Duarte
Cancer Center at Greater Baltimore Medical Center, Baltimore
University of New Mexico Cancer Research and Treatment Center, Albuquerque
Penn State Cancer Institute at Milton S. Hershey Medical Center, Hershey
Ottawa Regional Cancer Centre at Ottawa Hospital - General Campus, Ottawa
Regional Cancer Care at Thunder Bay Regional Health Sciences Centre, Thunder Bay
McGill Cancer Centre at McGill University, Montreal
Wellstat Therapeutics
INDUSTRY